Shorts

Rethinking First-Line Treatment for Atopic Dermatitis

What AbbVie’s Acquisition of Apogee Means for AD Treatment

When Patients Fear Their AD Medication

The Myths Surrounding Food Allergies and Atopic Dermatitis

Why Chronic Hand Eczema is More Than Just an Itch

Why Individualized Care Matters in the Age of "Preventative Botox"

Expanding Access and Promoting Purpose in Dermatology

How to Stop Patients from Following Unsafe Skin Care Trends

Bimatrizinol Becomes First New US Sunscreen Ingredient in 20 Years

Showing Patients Evidence of Sun Damage

Afamelanotide That Boosts Skin Photoprotection

Why Not All Microneedling Pens Are The Same

Resources for Clinicians From the Melanoma Research Foundation

Soquelitinib May Offer New Oral Treatment for Patients With AD

Why Rare Diseases Like EPP Are Frequently Misdiagnosed

Stop Calling Them Side Effects: Pro-Tips for Photodynamic Therapy

Why 86% of Patients Reported Feeling Better With This Hair Treatment

Celebrating National Sunscreen Day 2026

When Should You Actually Use Patch Testing?

The Sturge-Weber Foundation: Where Nobody Has to Hold Their Breath

The Evolving Role of Biotech in Skin Care Manufacturing

Dermatology News Update - May 21

Why Patients May Not Be Taking Your Skin Care Advice

Severe Pain With No Visible Signs: Erythropoietic Protoporphyria Insights

1.5x Better Hair Growth? Extended-Release Oral Minoxidil Explained

Could Improving Gut Health Also Improve Rosacea Symptoms?

Red Light vs Blue Light for sBCC: What the Data Says

Why Patients May Prefer PDT Over Surgery For sBCC

Don’t Be Rash: Fighting for Life-Changing HS Therapies in Pediatrics

Don’t Be Rash: Why Standard Biologics Don’t Work for Patients with Down Syndrome